Subacute inflammatory demyelinating polyneuropathy in children

Neurology. 2005 May 24;64(10):1786-8. doi: 10.1212/01.WNL.0000162047.89440.B9.

Abstract

Reported are five children with subacute demyelinating polyneuropathy. All patients had a monophasic disease, progressing over 4 to 8 weeks and characterized by predominantly motor features, areflexia, minimal or no cranial nerve abnormalities, no autonomic or respiratory involvement, elevated CSF protein, electrophysiologic evidence of demyelination, and good response to corticosteroids. A benign course with full recovery was the rule.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age Factors
  • Anti-Inflammatory Agents / administration & dosage
  • Child
  • Child, Preschool
  • Chronic Disease / classification
  • Disease Progression
  • Female
  • Humans
  • Male
  • Motor Neurons / physiology
  • Muscle Weakness / diagnosis
  • Muscle Weakness / etiology
  • Muscle Weakness / physiopathology
  • Muscle, Skeletal / innervation
  • Muscle, Skeletal / pathology
  • Muscle, Skeletal / physiopathology
  • Neural Conduction / drug effects
  • Neural Conduction / physiology
  • Paresis / diagnosis
  • Paresis / etiology
  • Paresis / physiopathology
  • Peripheral Nerves / pathology
  • Peripheral Nerves / physiopathology*
  • Polyradiculoneuropathy / classification
  • Polyradiculoneuropathy / diagnosis*
  • Polyradiculoneuropathy / physiopathology*
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / classification
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / diagnosis*
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / physiopathology*
  • Prednisolone / administration & dosage
  • Reflex, Abnormal / drug effects
  • Reflex, Abnormal / physiology
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Prednisolone